Endotoxin, Microbial, and Sterility Testing

Three test names, three different questions

Bacterial endotoxin testing looks for a defined class of pyrogenic material associated with gram-negative bacteria. Microbial enumeration estimates recoverable viable microorganisms under the stated culture conditions. A sterility test examines whether viable contaminating microorganisms are detected in the tested sample under the prescribed conditions. Those scopes overlap in quality programs but are not synonyms.

The EMA synthetic-peptide guideline lists bacterial endotoxins and microbiological purity as potentially relevant, separate specification attributes. The appropriate panel depends on the material, process, intended research protocol, risk assessment, and governing quality system. A website should therefore reproduce the test actually reported rather than apply one broad microbiological badge to every lot.

What an endotoxin result says

Bacterial endotoxins are not equivalent to all microorganisms or all pyrogens. FDA guidance discusses compendial bacterial endotoxin methods and emphasizes product-specific suitability because a sample can inhibit or enhance the test response. A negative or passing result is interpretable only with the method, dilution or suitability controls, unit, applicable limit, and identified sample.

A result may be reported numerically, below a stated threshold, or as conforming to an acceptance criterion. Preserve the exact wording and unit. Do not translate an endotoxin result into sterile, pyrogen-free, contaminant-free, or safe. FDA inspection guidance also notes that reducing viable microorganisms does not necessarily produce the same reduction in endotoxin burden.

What microbial enumeration says

Microbial enumeration procedures for nonsterile materials estimate aerobic mesophilic bacteria and fungi that can grow under defined test conditions. Results are commonly expressed using colony-forming units with a sample basis, but the method, sample preparation, incubation conditions, recovery controls, and reporting convention determine what the number means.

USP <61> describes enumeration tests for bacteria and fungi; it does not turn an acceptable count into a claim of sterility. A specification may also address specified objectionable organisms using other procedures. On a COA, terms such as microbial, microbiological purity, bioburden, and total count should be tied to the actual report rather than treated as interchangeable shorthand.

What a sterility test can and cannot establish

A compendial sterility test is a defined test for viable contaminating microorganisms in the units or portions sampled. USP <71> provides the procedural framework in its regulated context. The observed result applies to the sample and test conditions; it is not a census of every unit and should not be generalized to a different lot, presentation, or period after the container has been opened.

Sterility assurance is broader than a final test. FDA aseptic-processing guidance emphasizes controlled facilities, equipment, personnel, process validation, environmental monitoring, container-closure integrity, and investigations. A certificate line cannot replace those systems. Likewise, passing an endotoxin or microbial enumeration criterion does not establish a validated sterile manufacturing process.

Distinguish result language before comparing certificates

Not tested means the certificate provides no result for that attribute. Not detected means the target was not detected under the stated procedure and detection capability. Below limit means the reported response fell below a named threshold. Pass or conforms means the observation met a cited acceptance criterion. None of these phrases should be rewritten as absolute absence.

Also separate a method's reporting limit from a product specification. A certificate should identify the unit and basis, such as per mass, volume, or container, where applicable. When the method, unit, or limit is missing, document the gap and request the source report rather than borrowing a number from another material or a general standard.

• Match product, presentation, lot, sample identifier, report number, and date.
• Record the exact test name, method reference, result, unit, limit, and disposition.
• Check product-suitability, positive-control, or recovery information when the report provides it.
• Keep amended, invalidated, and superseded reports connected in the audit trail.

Use real records without extending their scope

The 5-Amino-1MQ COA family linked below includes records whose structured assay field explicitly lists endotoxin. That is an example of an endotoxin field, not an implied sterility result. The Korean Glutathione family includes records that explicitly list sterility and endotoxin, allowing readers to see that the attributes occupy separate fields even when they appear in one panel.

Always open the selected family record and confirm the exact lot and source document. Testing panels can change between lots, laboratories, and presentations. A current record cannot retroactively describe a historical batch, and a family-level page should not be used to imply that every listed assay appears on every attached report.

Keep the research-use boundary explicit

Test selection and acceptance criteria require material-specific expertise and an approved laboratory protocol. The FDA and USP resources linked here explain concepts within regulated scopes; they do not certify Phase One Labz, any third-party laboratory, or any listed research material. Their inclusion is educational and should not be represented as regulatory approval.

Nothing in a COA changes the labeled research-use-only status of a material. This page provides no preparation, administration, clinical, or veterinary guidance. Laboratories should follow applicable law, institutional biosafety requirements, controlled procedures, and the complete batch-specific documentation available to them.